Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants Post author: Post published: Post category:Uncategorized Agenda – Joint EMA-FDA workshop: Efficacy of monoclonal antibodies in the context of rapidly evolving SARS-CoV-2 variants You Might Also Like CHMP PROM agenda for the meeting on 17 January 2022 Agenda – CVMP agenda of the 12-14 July meeting ABDA
